[ad_1]
“The recommendation from the independent Agency for the Regulation of Medicines and Health Products to approve the Covid-19 vaccine has been accepted by Pfizer and Biontech,” the government said in a statement.
The statement added: “The vaccine will be available across Britain from next week,” according to the UK’s Sky News network.
“The NHS has decades of experience in providing large-scale vaccination programs, and will work to intensively prepare to provide care and support to all who can be vaccinated,” said the spokesperson for the Ministry of Health and Social Welfare.
The two companies, “Pfizer” and “Biontech”, have applied for a license to market their Corona vaccine in Europe.
The two groups said in a statement that they filed a request from the European Medicines Agency on Monday to “obtain a conditional license to market” their vaccine after tests showed it was 95% effective against Covid. -19.
And the statement said the vaccine “will be available in Europe by the end of 2020” in case it gets the necessary license, according to “AFP”.
“Pfizer” and its German partner, “Biontech” announced a few days ago that the results of the final experiments showed that their vaccine was 95% effective in preventing Covid-19 with no safety concerns.
The companies expect the U.S. Food and Drug Administration to grant approval for emergency use by mid-December.
Pfizer said it expects to have 50 million doses of the vaccine ready this year, enough to protect 25 million people.
And “Pfizer” has a deal to sell 100 million doses of its vaccine to the US government, and gives it the ability to purchase 500 million additional doses. The company is also in talks with other governments, including the European Union. , on similar agreements.
The vaccine from the two companies uses “mRNA” or “ribonucleic acid” technology, as it programs human cells to make copies of part of the virus, with the aim of stimulating the immune system to attack in case the real virus enters. in the body.
The announcement of the license application for the “Pfizer” vaccine against Covid-19 in Europe came after the US media reported that the first shipments of the “Pfizer” vaccine arrived in the United States from the company’s laboratory in Belgium. .
The Wall Street Journal and other media reported Pfizer was using charter flights to pre-prepare the vaccine for rapid distribution once approved in the United States.
And “Pfizer” CEO, Albert Burla, revealed last month the strategies the company will adopt to overcome obstacles to its vaccine.
According to Pfizer, its vaccine, which contains DNA or part of the genetic code of the virus, should be stored at a temperature between minus 70 and minus 80 degrees Celsius.
During his participation in a symposium organized by the American newspaper “New York Times”, Prank said that “Pfizer” is able to ship the vaccine to most areas of the United States of America in no more than a day.
In his speech, Prank touched on a number of technical and logistical aspects related to the property, such as the development of engineers at Pfizer for shipping container boxes that provide the temperature required to maintain the effectiveness of the vaccine, and also contain a GPS system. and an alarm that warns us in case of any defect in these boxes.
.
[ad_2]
Source link
